Live feed08:30:00·301dPRReleasevia QuantisnowPDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck CancerByQuantisnow·Wall Street's wire, on your screen.PDSB· PDS Biotechnology CorporationHealth Care
